2'-Fucosyllactose restores the intestinal mucosal barrier in ulcerative colitis by inhibiting STAT3 palmitoylation and phosphorylation

J Li, Y Wei, C Liu, X Guo, Z Liu, L Zhang, S Bao, X Wu… - Clinical Nutrition, 2024 - Elsevier
Summary Background & aims 2'-Fucosyllactose (2'-FL), the primary constituent of human
milk oligosaccharides, has been identified as a potential regulator of inflammation in …
相关文章

2'-Fucosyllactose restores the intestinal mucosal barrier in ulcerative colitis by inhibiting STAT3 palmitoylation and phosphorylation

J Li, Y Wei, C Liu, X Guo, Z Liu, L Zhang… - Clinical …, 2024 - clinicalnutritionjournal.com
Summary Background & aims 2'-Fucosyllactose (2'-FL), the primary constituent of human
milk oligosaccharides, has been identified as a potential regulator of inflammation in …

2'-Fucosyllactose restores the intestinal mucosal barrier in ulcerative colitis by inhibiting STAT3 palmitoylation and phosphorylation

J Li, Y Wei, C Liu, X Guo, Z Liu, L Zhang… - Clinical nutrition … - pubmed.ncbi.nlm.nih.gov
Background & aims 2'-Fucosyllactose (2'-FL), the primary constituent of human milk
oligosaccharides, has been identified as a potential regulator of inflammation in …

2'-Fucosyllactose restores the intestinal mucosal barrier in ulcerative colitis by inhibiting STAT3 palmitoylation and phosphorylation.

J Li, Y Wei, C Liu, X Guo, Z Liu, L Zhang… - Clinical Nutrition …, 2023 - europepmc.org
Methods C57BL/6J mice were orally administered a daily dose of 500 mg/kg 2'-FL for 11
consecutive days, followed by the induction of colitis using 3%(wt/vol) dextran sulfate …